[Genotype and phenotypic expression of hereditary hemochromatosis in Spain]

Gastroenterol Hepatol. 2004 Oct;27(8):437-43. doi: 10.1016/s0210-5705(03)70500-7.
[Article in Spanish]

Abstract

Introduction: The prevalence of C282Y homozygosity in patients with hereditary hemochromatosis (HH) has been reported to be markedly lower in the Mediterranean Basin than in northern Europe. In Spain, the available data are contradictory and limited to small series in specific regions. The objective of this study is to determine the prevalence of the 2 main HFE gene mutations in a large series of unrelated Spanish patients with HH from different geographical origins.

Patients and method: The criteria for HH diagnosis were: repeat serum transferrin saturation index (> 45% plus C282Y homozygosity and/or hepatic iron index (> 1.9 of dry liver weight in non-cirrhotic patients or (> 4.1 in patients with liver cirrhosis. Cases in related individuals were excluded. Demographic data, clinical expression, iron parameters and HFE gene mutations (C282Y and H63D) were assessed in 222 patients.

Results: A total of 83.3% of patients were C282Y homozygous and 5% were compound heterozygous (C282Y/H63D). No significant differences in phenotypic expression or in the frequency of C282Y homozygosity were observed between patients born in the North and South of Spain.

Conclusion: The genotypic and phenotypic expression of HH in Spain is very similar to that reported in Northern Europe. Thus, the genetic heterogeneity described in some Southern European regions cannot be considered a common feature to all countries of the Mediterranean Basin.

Publication types

  • Comparative Study
  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Female
  • Genotype*
  • Hemochromatosis / diagnosis
  • Hemochromatosis / epidemiology
  • Hemochromatosis / genetics*
  • Humans
  • Male
  • Middle Aged
  • Mutation
  • Phenotype*
  • Prevalence
  • Spain / epidemiology